The market is segmented based on Segmentation, By Speed (Hypersonic and Non-Hypersonic), Product (Tactical Missiles, Guided Rockets, Guided Ammunition, and Loitering Munition), Technology (Infrared, Semi-Active Lasers, Inertial Navigation System (INS), Global Positioning System (GPS), Radar Homing, Anti-Radiation, and Others), Type (Autonomous and Semi-Autonomous), End Use (Airborne, Land-base, and Naval) - Industry Trends and Forecast to 2032
.
The Global Precision Guided Munition Market size was valued at USD 44.20 USD Billion in 2024.
The Global Precision Guided Munition Market is projected to grow at a CAGR of 7.45% during the forecast period of 2025 to 2032.
The major players operating in the market include SARA Healthcare , Bayer AG , Scinopharm Taiwan , Rusan Pharma , and Sanofi .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.